Loading...
Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation
Pristimerin, a quinonemethide triterpenoid, has demonstrated anticancer activity against a number of types of cancer, including breast cancer. However, its mechanism of action remains unclear. The present study investigated the autophagy-induced anticancer efficacy of pristimerin on MDA-MB-231 human...
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172393/ https://ncbi.nlm.nih.gov/pubmed/30221728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2018.9488 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|